Cogent Biosciences Stock (NASDAQ: COGT) stock price, news, charts, stock research, profile.
Open | $7.750 |
Close | - |
Volume / Avg. | 456.205K / 2.086M |
Day Range | 7.425 - 7.830 |
52 Wk Range | 3.670 - 13.500 |
Market Cap | $732.408M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 14.68% |
Days to Cover | 9.97 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cogent Biosciences (NASDAQ: COGT) through any online brokerage.
Other companies in Cogent Biosciences’s space includes: Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE), Tango Therapeutics (NASDAQ:TNGX), Pharming (NASDAQ:PHAR) and AnaptysBio (NASDAQ:ANAB).
The latest price target for Cogent Biosciences (NASDAQ: COGT) was reported by Needham on Wednesday, May 8, 2024. The analyst firm set a price target for 18.00 expecting COGT to rise to within 12 months (a possible 134.98% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Cogent Biosciences (NASDAQ: COGT) is $7.6601 last updated Today at May 8, 2024 at 12:03 PM EDT.
There are no upcoming dividends for Cogent Biosciences.
Cogent Biosciences’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Cogent Biosciences.
Cogent Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.